Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 2

Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data

Pages
281–290
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While maternal autoimmune disease is not a prerequisite for the development of NLE, the existence of atruly “immunonegative” CHB is questionable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Neonatal lupus erythematosus (NLE) is an autoimmune syndrome caused by transplacental transmission of maternalautoantibodies, often with devastating consequences.
📊
Key Findings & Data:The objective of this systematic literature review was to analyze the demographicdata, geoepidemiology, clinical, and serological characteristics associated with NLE.Materials and methods: We performed a systematic literature search of the Pubmed database covering the period from 1976 to August2015, using the MeSH terms “neonatal lupus” or “congenital heart block”.
💡
Conclusion & Impact:While maternal autoimmune disease is not a prerequisite for the development of NLE, the existence of atruly “immunonegative” CHB is questionable.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Neonatal lupus erythematosus (NLE) is an autoimmune syndrome caused by transplacental transmission of maternalautoantibodies, often with devastating consequences. The objective of this systematic literature review was to analyze the demographicdata, geoepidemiology, clinical, and serological characteristics associated with NLE.Materials and methods: We performed a systematic literature search of the Pubmed database covering the period from 1976 to August2015, using the MeSH terms “neonatal lupus” or “congenital heart block”. To be included in the study, articles of any type (originalarticles, case series, and case reports) had to report on infants with NLE on an individualized (i.e. patient-by-patient) basis.Results: A total of 198 studies were included in the review, reporting on a total of 755 NLE patients. The most frequently reportedclinical manifestations of NLE were congenital heart block (CHB, 65.2%), cutaneous lupus (33.1%), and cytopenias (15.5%). We founddifferences in NLE characteristics based on study geographical origin, with CHB being much more frequent in patients of European orAmerican descent (49.4% and 35%, respectively), while reports originating from Asia reported a higher prevalence of skin involvement(45.2%). Most CHB cases (72.9%) were diagnosed between the 18th and 26th week of gestation.Conclusions: Phenotypic differences of NLE depending on race and country may reflect true pathophysiologic differences ormethodologic discrepancies. While maternal autoimmune disease is not a prerequisite for the development of NLE, the existence of atruly “immunonegative” CHB is questionable.

🔖

Cite This Article

ERDEN, A., ARMAĞAN, B., SENER, Y. Z., KİRAZ, S., SARI, A., KARADAĞ, Ö., CEYLAN, S., HYMABACCUS, B., KILIÇ, L., FANOURIAKIS, A., GÜRLER, F., BİLGİN, E., BOUMPAS, D. T. (2022). Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 2, 281–290. https://ajindex.com/articles/609677

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kurosaki K, Miyazaki A, Watanabe K, Echigo S. Long-term outcome of isolated congenital complete atrioventricular block pacing since neonatal period: experience at a single Japanese institution. Circulation Journal 2008; Official Journal of the Japanese Circulation Society 72 (1): 81-87 2. Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clinical Reviews in Allergy & Immunology 2017; 53 (3): 469-476. doi:10.1007/s12016-017-8653-0 3. Frankovich J, Sandborg C, Barnes P, Hintz S, Chakravarty E. Neonatal lupus and related autoimmune disorders of infants. NeoReviews 2008; 9 (5): e206-e217. doi:10.1542/neo.9-5-e206 4. Jayaprasad N, Johnson F, Venugopal K. Congenital complete heart block and maternal connective tissue disease. International Journal of Cardiology 2006; 112 (2): 153-158. doi:10.1016/j. ijcard.2005.11.115 5. Sonesson SE, Ambrosi A, Wahren-Herlenius M. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52- positive pregnancies. Ultrasound in Obstetrics & Gynecology 2019; 54 (1): 87-95. doi:10.1002/uog.20214 6. Lee LA. The clinical spectrum of neonatal lupus. Archives of Dermatological Research 2009; 301 (1): 107-110. doi:10.1007/ s00403-008-0896-4 7. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM et al. Long-term outcome of mothers of children with complete congenital heart block. American Journal of Medicine 1996; 100 (3): 328-332. doi:10.1016/S0002-9343(97)89492-2 8. Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clinical and Experimental Immunology 2008; 154 (1): 30-37. doi:10.1111/j.1365-2249.2008.03732.x 9. Moretti D, Cimaz R, Vannucci G, Marino A, De Martino M et al. Cutaneous neonatal lupus: a case report and review of the literature. International Journal of Dermatology 2014; 53 (12): 1508-1512. doi:10.1111/j.1365-4632.2012.05809.x 10. Levesque K, Morel N, Maltret A, Baron G, Masseau A et al. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. Autoimmunity Reviews 2015; 14 (12): 1154-1160. doi:10.1016/j. autrev.2015.08.005 11. Ho A, Gordon P, Rosenthal E, Simpson J, Miller O et al. Isolated complete heart block in the Fetus. American Journal of Cardiology 2015; 116 (1): 142-1